Liquidia shares jumped nearly 37% in premarket trading on Wednesday after the drugmaker settled a years-long legal ​dispute with United Therapeutics over its lung disease drug.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in